Sebastien Enault

Sebastien Enault is a seasoned professional with a diverse educational background and extensive experience in the pharmaceutical and biotechnology industries.

He holds a BSc in Pharmaceutical Industry from Avignon Université, a Master's degree in Biochemistry and Pharmacology from Université Nice Sophia Antipolis, and an MSc in Pharmacology Engineering Diploma from École Polytechnique.

Sebastien has held various key positions in reputable organizations, most notably serving as the Chief Business Officer at MedinCell.

Prior to his current role, he held the position of Chief Business Development Officer at DEINOVE and Eligo Bioscience.

His experience at MedinCell includes roles such as Head Product Portfolio Strategy, Director of Strategic Alliances, Manager of Business Development & Licensing, and Business Development Associate.

Before his tenure at MedinCell, Sebastien Enault worked as a Project Scientist at Harvard Medical School and Cancer Research UK, showcasing his expertise in the field.

Sebastien Enault's career trajectory demonstrates his strong business acumen and strategic leadership in the pharmaceutical and biotech sectors.